oltipraz has been researched along with Injury, Ischemia-Reperfusion in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acar, E; Altunrende, F; Can, O; Canat, L; Eraldemir, FC; Otunctemur, A; Sonmez, K; Yildirim, F | 1 |
| Cao, W; Chen, W; Ding, M; Guo, H; Lin, T; Wang, T; Wei, H; Yu, H; Zhang, C; Zhao, S; Zhao, X | 1 |
2 other study(ies) available for oltipraz and Injury, Ischemia-Reperfusion
| Article | Year |
|---|---|
Protective effect of oltipraz in testicular ischaemia/reperfusion injury: An experimental study.
Topics: Humans; Ischemia; Male; Malondialdehyde; Pyrazines; Rats; Reperfusion Injury; Spermatic Cord Torsion; Testis; Thiones; Thiophenes | 2022 |
Size and temporal-dependent efficacy of oltipraz-loaded PLGA nanoparticles for treatment of acute kidney injury and fibrosis.
Topics: Acute Kidney Injury; Animals; Antioxidants; Fibrosis; Mice; Nanoparticles; Particle Size; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrazines; Reperfusion Injury; Thiones; Thiophenes; Time Factors; Tissue Distribution; Treatment Outcome | 2019 |